Biomarkers in acute lung injury

Translational Research

Volumn 159, Issue 4, 2012, Pages 205-217

  Bhargava, Maneesh ^a   Wendt, Chris H ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; BIOLOGICAL MARKER; C REACTIVE PROTEIN; COLLAGEN; DESMOSINE; GLYCOPROTEIN; INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 8; KERATINOCYTE GROWTH FACTOR; LAMININ; LIPOPOLYSACCHARIDE BINDING PROTEIN; NITRIC OXIDE; PROTEIN C; PROTEOGLYCAN; SCATTER FACTOR; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; THROMBOMODULIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; BLOOD CLOTTING; BRONCHIOLE; CELL PROLIFERATION; ENDOTHELIUM INJURY; EPITHELIUM CELL; FIBROBLAST; HIGH RISK PATIENT; HUMAN; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; LUNG EDEMA; LUNG EXTRAVASCULAR FLUID; LUNG LAVAGE; MORTALITY; NONHUMAN; PANCREATITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY FAILURE; REVIEW; SENSITIVITY AND SPECIFICITY; SEPSIS; STAGING;

EID: 84858389340     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2012.01.007     Document Type: Review

References (114)

1. D.G. Ashbaugh, D.B. Bigelow, T.L. Petty, and B.E. Levine Acute respiratory distress in adults Lancet 2 1967 319 323
2. B.T. Suratt, and P.E. Parsons Mechanisms of acute lung injury/acute respiratory distress syndrome Clin Chest Med 27 2006 579 589 abstract viii
3. G.D. Rubenfeld, E. Caldwell, and E. Peabody Incidence and outcomes of acute lung injury N Engl J Med 353 2005 1685 1693
4. R.G. Brower, P.N. Lanken, and N. MacIntyre Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome N Engl J Med 351 2004 327 336
5. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The acute respiratory distress syndrome network N Engl J Med 342 2000 1301 1308
6. K.P. Steinberg, L.D. Hudson, and R.B. Goodman Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome N Engl J Med 354 2006 1671 1684
7. A.P. Wheeler, G.R. Bernard, and B.T. Thompson Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury N Engl J Med 354 2006 2213 2224
8. H.P. Wiedemann, A.P. Wheeler, and G.R. Bernard Comparison of two fluid-management strategies in acute lung injury N Engl J Med 354 2006 2564 2575
9. The ARDS Network Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial JAMA 283 2000 1995 2002
10. Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome Crit Care Med 30 2002 1 6
11. R. Jain, and A. DalNogare Pharmacological therapy for acute respiratory distress syndrome Mayo Clin Proc 81 2006 205 212
12. R.D. Stapleton, B.M. Wang, L.D. Hudson, G.D. Rubenfeld, E.S. Caldwell, and K.P. Steinberg Causes and timing of death in patients with ARDS Chest 128 2005 525 532
13. G.R. Bernard, A. Artigas, and K.L. Brigham Report of the American-European Consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee J Crit Care 9 1994 72 81
14. M.S. Herridge, and D.C. Angus Acute lung injury-affecting many lives N Engl J Med 353 2005 1736 1738
15. V.G. De Gruttola, P. Clax, and D.L. DeMets Considerations in the evaluation of surrogate endpoints in clinical trials. Summary of a National Institutes of Health workshop Control Clin Trials 22 2001 485 502
16. H. Gerlach, and S. Toussaint Sensitive, specific, predictive.... statistical basics: how to use biomarkers Crit Care Clin 27 2011 215 227
17. O. Roca, S. Gomez-Olles, M.J. Cruz, X. Munoz, M.J. Griffiths, and J.R. Masclans Effects of salbutamol on exhaled breath condensate biomarkers in acute lung injury: prospective analysis Crit Care 12 2008 R72
18. U. Sack, R. Scheibe, and M. Wotzel Multiplex analysis of cytokines in exhaled breath condensate Cytometry 69 2006 169 172
19. D.E. McClintock, B. Starcher, and M.D. Eisner Higher urine desmosine levels are associated with mortality in patients with acute lung injury Am J Physiol Lung Cell Mol Physiol 291 2006 L566 L571
20. D.E. McClintock, L.B. Ware, M.D. Eisner, N. Wickersham, B.T. Thompson, and M.A. Matthay Higher urine nitric oxide is associated with improved outcomes in patients with acute lung injury Am J Respir Crit Care Med 175 2007 256 262
21. E.R. Conner, L.B. Ware, G. Modin, and M.A. Matthay Elevated pulmonary edema fluid concentrations of soluble intercellular adhesion molecule-1 in patients with acute lung injury: biological and clinical significance Chest 116 1 Suppl 1999 83S 84S
22. J.A. Kropski, R.D. Fremont, C.S. Calfee, and L.B. Ware Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury Chest 135 2009 1440 1447
23. P. Prabhakaran, L.B. Ware, K.E. White, M.T. Cross, M.A. Matthay, and M.A. Olman Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury Am J Physiol Lung Cell Mol Physiol 285 2003 L20 L28
24. A.-L.A. Katzenstein Katzenstein and Askin's surgical pathology of non-neoplastic lung disease 4th ed. 2006 Saunders, Chapter 2, Figure 2.1 Philadelphia 18
25. L.B. Ware, and M.A. Matthay The acute respiratory distress syndrome N Engl J Med 342 2000 1334 1349
26. L.J. Cross, and M.A. Matthay Biomarkers in acute lung injury: insights into the pathogenesis of acute lung injury Crit Care Clin 27 2011 355 377
27. C.S. Calfee, M.D. Eisner, and L.B. Ware Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders Crit Care Med 35 2007 2243 2250
28. P.E. Parsons, M.D. Eisner, and B.T. Thompson Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury Crit Care Med 33 2005 1 6 discussion 230-2
29. P.E. Parsons, M.A. Matthay, L.B. Ware, and M.D. Eisner Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury Am J Physiol Lung Cell Mol Physiol 288 2005 L426 L431
30. P.E. Parsons, F.A. Moore, E.E. Moore, D.N. Ikle, P.M. Henson, and G.S. Worthen Studies on the role of tumor necrosis factor in adult respiratory distress syndrome Am Rev Respir Dis 146 1992 694 700
31. J.D. Marks, C.B. Marks, and J.M. Luce Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration Am Rev Respir Dis 141 1990 94 97
32. R. Roten, M. Markert, F. Feihl, M.D. Schaller, M.C. Tagan, and C. Perret Plasma levels of tumor necrosis factor in the adult respiratory distress syndrome Am Rev Respir Dis 143 1991 590 592
33. T.M. Hyers, S.M. Tricomi, P.A. Dettenmeier, and A.A. Fowler Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome Am Rev Respir Dis 144 1991 268 271
34. N.P. O'Grady, H.L. Preas, and J. Pugin Local inflammatory responses following bronchial endotoxin instillation in humans Am J Respir Crit Care Med 163 2001 1591 1598
35. D. Bouros, M.G. Alexandrakis, and K.M. Antoniou The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for acute respiratory distress syndrome BMC Pulm Med 4 2004 6
36. A. Takala, I. Jousela, and O. Takkunen A prospective study of inflammation markers in patients at risk of indirect acute lung injury Shock 17 2002 252 257
37. G.U. Meduri, S. Headley, and G. Kohler Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time Chest 107 1995 1062 1073
38. S.C. Donnelly, R.M. Strieter, and S.L. Kunkel Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups Lancet 341 1993 643 647
39. P.G. Jorens, J. Van Damme, and W. De Backer Interleukin 8 (IL-8) in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS Cytokine 4 1992 592 597
40. H. Schutte, J. Lohmeyer, and S. Rosseau Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema Eur Respir J 9 1996 1858 1867
41. R.F. Jacobs, D.R. Tabor, and A.W. Burks Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome Am Rev Respir Dis 140 1989 1686 1692
42. J. Pugin, G. Verghese, M.C. Widmer, and M.A. Matthay The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome Crit Care Med 27 1999 304 312
43. J. Pugin, B. Ricou, and K.P. Steinberg Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1 Am J Respir Crit Care Med 153 6 Pt 1 1996 1850 1856
44. P.M. Suter, S. Suter, E. Girardin, P. Roux-Lombard, G.E. Grau, and J.M. Dayer High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase in patients with adult respiratory distress syndrome after trauma, shock, or sepsis Am Rev Respir Dis 145 1992 1016 1022
45. W.Y. Park, R.B. Goodman, and K.P. Steinberg Cytokine balance in the lungs of patients with acute respiratory distress syndrome Am J Respir Crit Care Med 164 10 Pt 1 2001 1896 1903
46. M.J. Cohen, K. Brohi, and C.S. Calfee Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion Crit Care 13 2009 R174
47. J. Villar, L. Perez-Mendez, and E. Espinosa Serum lipopolysaccharide binding protein levels predict severity of lung injury and mortality in patients with severe sepsis PLoS One 4 2009 e6818
48. E.K. Bajwa, U.A. Khan, J.L. Januzzi, M.N. Gong, B.T. Thompson, and D.C. Christiani Plasma C-reactive protein levels are associated with improved outcome in ARDS Chest 136 2009 471 480
49. K.E. Greene, J.R. Wright, and K.P. Steinberg Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS Am J Respir Crit Care Med 160 1999 1843 1850
50. K.E. Greene, S. Ye, R.J. Mason, and P.E. Parsons Serum surfactant protein-A levels predict development of ARDS in at-risk patients Chest 116 1 Suppl 1999 90S 91S
51. A.D. Bersten, T. Hunt, T.E. Nicholas, and I.R. Doyle Elevated plasma surfactant protein-B predicts development of acute respiratory distress syndrome in patients with acute respiratory failure Am J Respir Crit Care Med 164 2001 648 652
52. M.D. Eisner, P. Parsons, M.A. Matthay, L. Ware, and K. Greene Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury Thorax 58 2003 983 988
53. M.N. Gong, Z. Wei, L.L. Xu, D.P. Miller, B.T. Thompson, and D.C. Christiani Polymorphism in the surfactant protein-B gene, gender, and the risk of direct pulmonary injury and ARDS Chest 125 2004 203 211
54. J. Kobayashi, and S. Kitamura KL-6: a serum marker for interstitial pneumonia Chest 108 1995 311 315
55. A. Ishizaka, T. Matsuda, and K.H. Albertine Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome Am J Physiol Lung Cell Mol Physiol 286 2004 L1088 L1094
56. A. Bierhaus, P.M. Humpert, and M. Morcos Understanding RAGE, the receptor for advanced glycation end products J Mol Med (Berl) 83 2005 876 886
57. T. Uchida, M. Shirasawa, and L.B. Ware Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury Am J Respir Crit Care Med 173 2006 1008 1015
58. C.S. Calfee, L.B. Ware, and M.D. Eisner Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury Thorax 63 2008 1083 1089
59. R.D. Fremont, T. Koyama, and C.S. Calfee Acute lung injury in patients with traumatic injuries: utility of a panel of biomarkers for diagnosis and pathogenesis J Trauma 68 2010 1121 1127
60. I. Dierynck, A. Bernard, H. Roels, and M. De Ley The human Clara cell protein: biochemical and biological characterisation of a natural immunosuppressor Mult Scler 1 1996 385 387
61. O. Lesur, S. Langevin, and Y. Berthiaume Outcome value of Clara cell protein in serum of patients with acute respiratory distress syndrome Intensive Care Med 32 2006 1167 1174
62. R.M. Determann, J.L. Millo, S. Waddy, R. Lutter, C.S. Garrard, and M.J. Schultz Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilator-associated pneumonia: a retrospective observational study BMC Pulm Med 9 2009 49
63. M. Katayama, A. Ishizaka, and M. Sakamoto Laminin gamma2 fragments are increased in the circulation of patients with early phase acute lung injury Intensive Care Med 36 2010 479 486
64. A.C. Carvalho, S.M. Bellman, V.J. Saullo, D. Quinn, and W.M. Zapol Altered factor VIII in acute respiratory failure N Engl J Med 307 1982 1113 1119
65. D.B. Rubin, and J.P. Wiener-Kronish Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome J Clin Invest 86 1990 474 480
66. M.S. Bajaj, and S.M. Tricomi Plasma levels of the three endothelial-specific proteins von Willebrand factor, tissue factor pathway inhibitor, and thrombomodulin do not predict the development of acute respiratory distress syndrome Intensive Care Med 25 1999 1259 1266
67. M. Moss, L. Ackerson, M.K. Gillespie, F.A. Moore, E.E. Moore, and P.E. Parsons von Willebrand factor antigen levels are not predictive for the adult respiratory distress syndrome Am J Respir Crit Care Med 151 1995 15 20
68. L.B. Ware, M.D. Eisner, B.T. Thompson, P.E. Parsons, and M.A. Matthay Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury Am J Respir Crit Care Med 170 2004 766 772
69. C.S. Calfee, M.D. Eisner, and P.E. Parsons Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury Intensive Care Med 35 2009 248 257
70. P. Agouridakis, D. Kyriakou, and M.G. Alexandrakis The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome Respir Res 3 2002 25
71. H.R. Flori, L.B. Ware, D. Glidden, and M.A. Matthay Early elevation of plasma soluble intercellular adhesion molecule-1 in pediatric acute lung injury identifies patients at increased risk of death and prolonged mechanical ventilation Pediatr Crit Care Med 4 2003 315 321
72. D.C. Gallagher, S.M. Parikh, and K. Balonov Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome Shock 29 2008 656 661
73. N.J. Meyer, M. Li, and R. Feng ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio Am J Respir Crit Care Med 183 2011 1344 1353
74. T. Ong, D.E. McClintock, R.H. Kallet, L.B. Ware, M.A. Matthay, and K.D. Liu Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients Crit Care Med 38 2010 1845 1851
75. J. Boldt, M. Wollbruck, D. Kuhn, L.C. Linke, and G. Hempelmann Do plasma levels of circulating soluble adhesion molecules differ between surviving and nonsurviving critically ill patients? Chest 107 1995 787 792
76. K. Okajima, N. Harada, and G. Sakurai Rapid assay for plasma soluble E-selectin predicts the development of acute respiratory distress syndrome in patients with systemic inflammatory response syndrome Transl Res 148 2006 295 300
77. S. Idell, K.K. James, and E.G. Levin Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome J Clin Invest 84 1989 695 705
78. S. Idell, K.B. Koenig, D.S. Fair, T.R. Martin, J. McLarty, and R.J. Maunder Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome Am J Physiol 261 4 Pt 1 1991 L240 L248
79. P.B. Bitterman, S.I. Rennard, S. Adelberg, and R.G. Crystal Role of fibronectin as a growth factor for fibroblasts J Cell Biol 97 1983 1925 1932
80. F. Grinnell, M. Feld, and D. Minter Fibroblast adhesion to fibrinogen and fibrin substrata: requirement for cold-insoluble globulin (plasma fibronectin) Cell 19 1980 517 525
81. W. Seeger, J. Hubel, and K. Klapettek Procoagulant activity in bronchoalveolar lavage of severely traumatized patients-relation to the development of acute respiratory distress Thromb Res 61 1991 53 64
82. P. Bertozzi, B. Astedt, and L. Zenzius Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome N Engl J Med 322 1990 890 897
83. R.M. Senior, W.F. Skogen, G.L. Griffin, and G.D. Wilner Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B J Clin Invest 77 1986 1014 1019
84. K.J. Leavell, M.W. Peterson, and T.J. Gross The role of fibrin degradation products in neutrophil recruitment to the lung Am J Respir Cell Mol Biol 14 1996 53 60
85. W. Seeger, A. Elssner, A. Gunther, H.J. Kramer, and H.O. Kalinowski Lung surfactant phospholipids associate with polymerizing fibrin: loss of surface activity Am J Respir Cell Mol Biol 9 1993 213 220
86. A. Gunther, P. Mosavi, and S. Heinemann Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome Am J Respir Crit Care Med 161 2 Pt 1 2000 454 462
87. L.B. Ware, X. Fang, and M.A. Matthay Protein C and thrombomodulin in human acute lung injury Am J Physiol Lung Cell Mol Physiol 285 2003 L514 L521
88. D. McClintock, H. Zhuo, N. Wickersham, M.A. Matthay, and L.B. Ware Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury Crit Care 12 2008 R41
89. J.F. Tomashefski Jr. Pulmonary pathology of acute respiratory distress syndrome Clin Chest Med 21 2000 435 466
90. N. Chelly, O.B. Mouhieddine-Gueddiche, A.M. Barlier-Mur, B. Chailley-Heu, and J.R. Bourbon Keratinocyte growth factor enhances maturation of fetal rat lung type II cells Am J Respir Cell Mol Biol 20 1999 423 432
91. D.M. Danilenko Preclinical and early clinical development of keratinocyte growth factor, an epithelial-specific tissue growth factor Toxicol Pathol 27 1999 64 71
92. R.R. Deterding, C.R. Jacoby, and J.M. Shannon Acidic fibroblast growth factor and keratinocyte growth factor stimulate fetal rat pulmonary epithelial growth Am J Physiol 271 4 Pt 1 1996 L495 L505
93. L.B. Ware, and M.A. Matthay Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair Am J Physiol Lung Cell Mol Physiol 282 2002 L924 L940
94. J.B. Stern, L. Fierobe, and C. Paugam Keratinocyte growth factor and hepatocyte growth factor in bronchoalveolar lavage fluid in acute respiratory distress syndrome patients Crit Care Med 28 2000 2326 2333
95. G.M. Verghese, K. McCormick-Shannon, R.J. Mason, and M.A. Matthay Hepatocyte growth factor and keratinocyte growth factor in the pulmonary edema fluid of patients with acute lung injury. Biologic and clinical significance Am J Respir Crit Care Med 158 1998 386 394
96. D.R. Thickett, L. Armstrong, S.J. Christie, and A.B. Millar Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome Am J Respir Crit Care Med 164 2001 1601 1605
97. D.R. Thickett, L. Armstrong, and A.B. Millar A role for vascular endothelial growth factor in acute and resolving lung injury Am J Respir Crit Care Med 166 2002 1332 1337
98. B. Maitre, S. Boussat, and D. Jean Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury Eur Respir J 18 2001 100 106
99. L.B. Ware, R.J. Kaner, and R.G. Crystal VEGF levels in the alveolar compartment do not distinguish between ARDS and hydrostatic pulmonary oedema Eur Respir J 26 2005 101 105
100. A.N. Chesnutt, M.A. Matthay, F.A. Tibayan, and J.G. Clark Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance Am J Respir Crit Care Med 156 3 Pt 1 1997 840 845
101. J.G. Clark, J.A. Milberg, K.P. Steinberg, and L.D. Hudson Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death Ann Intern Med 122 1995 17 23
102. G.U. Meduri, E.A. Tolley, A. Chinn, F. Stentz, and A. Postlethwaite Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment Am J Respir Crit Care Med 158 5 Pt 1 1998 1432 1441
103. R.P. Marshall, G. Bellingan, and S. Webb Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome Am J Respir Crit Care Med 162 2000 1783 1788
104. O. Gajic, B. Afessa, and B.T. Thompson Prediction of death and prolonged mechanical ventilation in acute lung injury Crit Care 11 2007 R53
105. O. Gajic, O. Dabbagh, and P.K. Park Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study Am J Respir Crit Care Med 183 2011 462 470
106. C. Trillo-Alvarez, R. Cartin-Ceba, and D.J. Kor Acute lung injury prediction score: derivation and validation in a population-based sample Eur Respir J 37 2011 604 609
107. L.B. Ware, T. Koyama, and D.D. Billheimer Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury Chest 137 2010 288 296
108. Z. Wang, D. Beach, L. Su, R. Zhai, and D.C. Christiani A genome-wide expression analysis in blood identifies pre-elafin as a biomarker in ARDS Am J Respir Cell Mol Biol 38 2008 724 732
109. M.N. Gong, W. Zhou, P.L. Williams, B.T. Thompson, L. Pothier, and P. Boyce -308GA and TNFB polymorphisms in acute respiratory distress syndrome Eur Respir J 26 2005 382 389
110. A.M. Sutherland, K.R. Walley, S. Manocha, and J.A. Russell The association of interleukin 6 haplotype clades with mortality in critically ill adults Arch Intern Med 165 2005 75 82
111. M.N. Gong, B.T. Thompson, and P.L. Williams Interleukin-10 polymorphism in position -1082 and acute respiratory distress syndrome Eur Respir J 27 2006 674 681
112. D.W. Chang, S. Hayashi, and S.A. Gharib Proteomic and computational analysis of bronchoalveolar proteins during the course of the acute respiratory distress syndrome Am J Respir Crit Care Med 178 2008 701 709
113. L.M. Schnapp, S. Donohoe, and J. Chen Mining the acute respiratory distress syndrome proteome: identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injury Am J Pathol 169 2006 86 95
114. K.A. Stringer, N.J. Serkova, A. Karnovsky, K. Guire, R. Paine III, and T.J. Standiford Metabolic consequences of sepsis-induced acute lung injury revealed by plasma (1)H-nuclear magnetic resonance quantitative metabolomics and computational analysis Am J Physiol Lung Cell Mol Physiol 300 2011 L4 L11